Reversing Epigenetic Gene Silencing to Overcome Immune Evasion in CNS Malignancies

Glioblastoma (GBM) is an aggressive brain malignancy with a dismal prognosis. With emerging evidence to disprove brain-immune privilege, there has been much interest in examining immunotherapy strategies to treat central nervous system (CNS) cancers. Unfortunately, the limited success of clinical st...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Oncol
Autors principals: Ratnam, Nivedita M., Sonnemann, Heather M., Frederico, Stephen C., Chen, Huanwen, Hutchinson, Marsha-Kay N. D., Dowdy, Tyrone, Reid, Caitlin M., Jung, Jinkyu, Zhang, Wei, Song, Hua, Zhang, Meili, Davis, Dionne, Larion, Mioara, Giles, Amber J., Gilbert, Mark R.
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2021
Matèries:
Oncology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8320893/
https://ncbi.nlm.nih.gov/pubmed/34336705
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.719091
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars